“…This observation can be explained by the high portion of marketed drugs based on heterocyclic cores, mostly containing N atoms with a high propensity for proton tautomerism (de la Torre & Albericio, 2023). Amino derivatives of 4-thiazolidinones are also prone to tautomerism, but structural studies have focused so far on the synthetically more accessible 2-amino-4-thiazolidinones rather than on the isomeric 4-amino-2-thiazolidinones (Ramsh et al, 1985;Engoyan et al, 1978;Kowiel, 2015). These compounds are of great interest because of their pharmaceutical potential, which includes anticancer (Roszczenko et al, 2022), antibacterial (Tratrat et al, 2022), antitrypanosomal (Krysh-chyshyn et al, 2019) and many other biological activities (Nirwan et al, 2019;Seboletswe et al, 2023).…”